| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
11,317 |
9,648 |
$6.99M |
| A0425 |
Ground mileage, per statute mile |
20,400 |
15,913 |
$4.10M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
5,392 |
4,690 |
$2.72M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
37,895 |
34,011 |
$2.52M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,590 |
3,324 |
$846K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,428 |
4,151 |
$832K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
1,776 |
1,405 |
$537K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,731 |
2,468 |
$236K |
| 36415 |
Collection of venous blood by venipuncture |
14,246 |
12,189 |
$178K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
499 |
452 |
$152K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,055 |
999 |
$107K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
126 |
118 |
$89K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
392 |
357 |
$43K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
382 |
345 |
$37K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
376 |
339 |
$36K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
963 |
900 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
466 |
435 |
$19K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
40 |
28 |
$18K |
| 80053 |
Comprehensive metabolic panel |
2,134 |
1,911 |
$13K |
| 97803 |
|
154 |
148 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
248 |
214 |
$12K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
60 |
31 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,977 |
2,710 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,442 |
6,734 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
204 |
187 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,050 |
1,002 |
$9K |
| 87631 |
|
52 |
51 |
$7K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
27 |
24 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
80 |
71 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
494 |
475 |
$3K |
| 80061 |
Lipid panel |
197 |
192 |
$3K |
| 84439 |
|
567 |
541 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$2K |
| 99000 |
|
59 |
45 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
37 |
14 |
$2K |
| 97597 |
|
29 |
12 |
$2K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
244 |
237 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
30 |
12 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
14 |
12 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
140 |
117 |
$1K |
| 84480 |
|
230 |
222 |
$1K |
| 81001 |
|
492 |
449 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
14 |
14 |
$1K |
| A9270 |
Non-covered item or service |
210 |
174 |
$967.49 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
140 |
134 |
$909.48 |
| 92557 |
|
12 |
12 |
$907.74 |
| 0002A |
|
51 |
48 |
$900.02 |
| 0001A |
|
56 |
53 |
$849.44 |
| 94726 |
|
12 |
12 |
$721.92 |
| 0004A |
|
32 |
26 |
$559.20 |
| 94729 |
|
37 |
37 |
$503.87 |
| 0124A |
|
16 |
14 |
$416.93 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
16 |
$322.41 |
| 85027 |
|
342 |
302 |
$315.53 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,047 |
980 |
$314.47 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,133 |
1,058 |
$260.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$251.56 |
| 92567 |
|
27 |
27 |
$233.26 |
| 80306 |
|
13 |
12 |
$158.02 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
124 |
98 |
$147.43 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
40 |
40 |
$147.27 |
| 87081 |
|
18 |
18 |
$127.64 |
| 80051 |
|
29 |
24 |
$110.80 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
14 |
13 |
$80.83 |
| 82947 |
|
30 |
25 |
$64.86 |
| 84520 |
|
29 |
24 |
$44.53 |
| 82310 |
|
14 |
12 |
$27.75 |
| 81025 |
|
16 |
13 |
$0.00 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
50 |
24 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$0.00 |
| 83605 |
|
15 |
14 |
$0.00 |
| 83690 |
|
42 |
40 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
12 |
12 |
$0.00 |